NCT02993705View on ClinicalTrials.gov

Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 22, 2017

Primary Completion Date

November 13, 2019

Study Completion Date

November 13, 2019

Conditions
Carcinosarcoma, OvarianCarcinosarcomas Uterine
Interventions
DRUG

Trabectedin

Chemotherapy drug

Trial Locations (1)

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT02993705 - Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS) | Biotech Hunter | Biotech Hunter